Use of notch pathway interfering agents for treatment of...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01)

Patent

CA 2546017

The present invention provides a method for reducing the severity of, or treatment of, plasma cell disorders. The method comprises the step of administering to an individual afflicted with a plasma cell disorder, a composition comprising an antibody directed to the extracellular portion of NOTCH or to JAG2.

L'invention concerne un procédé permettant de réduire la sévérité, ou le traitement des troubles plasmocytaires : administration à une personne souffrant de tels troubles d'une composition qui renferme un anticorps 5 orienté vers la partie extra-cellulaire du NOTCH ou vers JAG2.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of notch pathway interfering agents for treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of notch pathway interfering agents for treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of notch pathway interfering agents for treatment of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1732057

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.